

The Shadow of Vaccines Revealed by the Costaive Controversy: Lessons for the Future on Establishing Safety Evaluations
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan The new coronavirus vaccine "Costaive," developed by Meiji Seika Pharma (a subsidiary of Meiji Holdings), has garnered significant public attention. Social media is flooded with misinformation, including claims that vaccinated individuals can infect others through 'shedding'. Meiji has initiated defamation lawsuits against anti-vaccine groups that have led the spread of these falsehoods.
Apr 6, 2025


Pharmaceutical Economics Column: Exploring the Economics of Medications (Part 142)Potentially Inappropriate Prescribing in Ireland
Tetsuya Tanimoto, M.D. Medical Governance Research Institute, Tokyo, Japan In spring 2023, our pharmaceutical conflicts of interest research group participated in an international conference in Bath, UK. There, we had the pleasure of meeting Professor Tom Fahey from the Royal College of Surgeons in Ireland. While Ireland is a small nation with an estimated population of 5.28 million in 2023, it boasts a young demographic and impressive economic metrics. According to the IMF,
Mar 28, 2025


Medical Renaissance54. Japan is 20 years behind the United States - The Beni-Koji (red yeast rice) issue is a good opportunity to think about the state of Japanese society.
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan Anything made by humans cannot eliminate the...
Mar 14, 2025


Boston Wellness News Part 2: A surprising number of people stop taking popular weight loss drugs (3/3)
Mutsuko Ohnishi, MD, Internal medicine physician in Boston, USA Continuing from the previous article, today’s topic is also about the...
Feb 28, 2025


Thoughts from a doctor whose grandparents have dementia.Does the herpes zoster vaccine lower the risk? Research publications continue to emerge.
Kana Yamamoto, M.D., Ph.D Physician, Medical Governance Research Institute The Japan Meteorological Agency (※1) announced on August 1st...
Feb 14, 2025


Lasker Award and GLP-1
Accessible Rail Medical Services Tetsuikai, Navitas Clinic Kawasaki, Tetsuya Tanimoto, MD GLP-1 receptor agonists are very popular around...
Jan 31, 2025


Reviewing the Fukushima Prefectural Ohno Hospital Incident(2/2)
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan However, this incident occurred in Fukushima, Mr. Munakata's home prefecture. Perhaps he had an interest due to it being about his hometown. He said, "Since a junior asked," and introduced me to an excellent female staff member. She came to the medical research lab at Tokyo University and spent about two hours listening to the situation. After hearing my explanation, she said, "It's not
Jan 17, 2025


Reviewing the Fukushima Prefectural Ohno Hospital Incident(1/2)
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan I recently had the opportunity to revisit the 2006 arrest incident of an obstetrician at Fukushima Prefectural Ohno Hospital. This was due to assisting Yuria Iyano, a student from Yokohama City University Medical School, with her report. Ms. Iyano chose to study under Professor Suzuki at the Graduate School of Public Policy, University of Tokyo, as part of her external training curriculu
Dec 25, 2024


The Catastrophe of Conditional Approval Systems
Accessible Rail Medical Services Tetsuikai, Navitas Clinic Kawasaki Tetsuya Tanimoto, MD Terumo’s regenerative medicine product for heart failure treatment, "HeartSheet," achieved the world’s first practical application and received manufacturing and marketing approval in Japan in September 2015. However, on July 19th, it was confirmed at the Ministry of Health, Labour and Welfare’s Pharmaceutical Affairs Council Subcommittee on Regenerative Medicine Products and Biological T
Dec 20, 2024


People Easily Become Prey to Power: Mechanisms and Countermeasures for Sport Harassment Among Martial Arts Instructors
Akiko Fujii, Psychotherapist, Japan Air Self-Defense Force Akiko Fujii, clinical psychologist, certified psychologist, and PhD in Education, has worked in city welfare and as an emergency dispatch counselor in Fukushima Prefecture before her current position. In addition to counseling, she is dedicated to resilience education and harassment prevention training. The Unique Aspect of Martial Arts One distinguishing element of traditional Japanese martial arts, such as Kendo, se
Dec 6, 2024


"Cancer Before Age 49" Increases by 80% Over 30 Years: Revealing Why Younger Cancer Patients Are On the Rise Globally
Mutsuko Ohnishi, MD, Internal medicine physician in Boston, USA Researchers from Harvard University reported in September last year that...
Nov 22, 2024


Exploring the Earth Beneath: Radar Technology in Geological Surveys ~Professor Tsubokura's Radiation Classroom~
Masaharu Tsubokura, M.D., Ph.D. Chief Professor, Department of Radiation Health Management, School of Medicine, Fukushima Medical...
Nov 8, 2024


Positive Health Training Experience - A New Concept of Health from the Netherlands - ②
Makoto Kosaka, Orange Home-care Clinic I have completed my initial training and now work at the Orange Home Care Clinic, specializing in...
Oct 25, 2024


The Issue of “Tuition Fees for International Students Being Too Low” Overlooked in the Discussion of the University of Tokyo’s “Tuition Fee Hike”(2/2)
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan The Biggest Problem: “20 Years of Low Growth Since Incorporation” On a global scale, the University of Tokyo’s biggest problem is its lack of growth since its incorporation as a national university corporation in 2004. According to materials prepared for the “Special Research University Survey Committee of the Council for Science, Technology and Innovation,” excluding hospital revenue
Oct 11, 2024


The Issue of “Tuition Fees for International Students Being Too Low” Overlooked in the Discussion of the University of Tokyo’s “Tuition Fee Hike”(1/2)
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan Enhancing international competitiveness requires funding. However, the ongoing debate about the University of Tokyo’s “tuition fee hike” is ignoring a crucial issue. It is true that the financial situation of the University of Tokyo is weak, and that its fund management is inferior. Yet, in recent years, the university has lagged behind the trend where top Western universities have sign
Sep 28, 2024




















